世界の前立腺がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prostate Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4771 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、前立腺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・前立腺がん分子診断の市場動向 ・企業の競争状況、市場シェア ・前立腺がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・前立腺がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・前立腺がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・前立腺がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Qiagen、Foundationmedicine、Genetech、Gpmedical、Premed、Berryoncology、Gene+、Annoroad、Topgen、Geneis） ・結論

A molecular approach for diagnosing prostate cancer

Market Analysis and Insights: Global Prostate Cancer Molecular Diagnostics Market
The global Prostate Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Molecular Diagnostics market.

Global Prostate Cancer Molecular Diagnostics Scope and Market Size
Prostate Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Qiagen
Foundationmedicine
Genetech
Gpmedical
Premed
Berryoncology
Gene+
Annoroad
Topgen
Geneis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Prostate Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Prostate Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Prostate Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Prostate Cancer Molecular Diagnostics Market Trends
2.3.2 Prostate Cancer Molecular Diagnostics Market Drivers
2.3.3 Prostate Cancer Molecular Diagnostics Market Challenges
2.3.4 Prostate Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Molecular Diagnostics Revenue
3.4 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Molecular Diagnostics Revenue in 2020
3.5 Prostate Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Prostate Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Prostate Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Prostate Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Prostate Cancer Molecular Diagnostics Introduction
11.1.4 Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Qiagen Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Foundationmedicine Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Prostate Cancer Molecular Diagnostics Introduction
11.3.4 Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Genetech Recent Development
11.4 Gpmedical
11.4.1 Gpmedical Company Details
11.4.2 Gpmedical Business Overview
11.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Introduction
11.4.4 Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Gpmedical Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Prostate Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Berryoncology Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Prostate Cancer Molecular Diagnostics Introduction
11.7.4 Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Gene+ Recent Development
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Prostate Cancer Molecular Diagnostics Introduction
11.8.4 Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Annoroad Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Prostate Cancer Molecular Diagnostics Introduction
11.9.4 Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Topgen Recent Development
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Prostate Cancer Molecular Diagnostics Introduction
11.10.4 Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Geneis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Prostate Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prostate Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prostate Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Prostate Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Prostate Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Prostate Cancer Molecular Diagnostics Market Trends
Table 13. Prostate Cancer Molecular Diagnostics Market Drivers
Table 14. Prostate Cancer Molecular Diagnostics Market Challenges
Table 15. Prostate Cancer Molecular Diagnostics Market Restraints
Table 16. Global Prostate Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Prostate Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Prostate Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Prostate Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Qiagen Company Details
Table 64. Qiagen Business Overview
Table 65. Qiagen Prostate Cancer Molecular Diagnostics Product
Table 66. Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Qiagen Recent Development
Table 68. Foundationmedicine Company Details
Table 69. Foundationmedicine Business Overview
Table 70. Foundationmedicine Prostate Cancer Molecular Diagnostics Product
Table 71. Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Foundationmedicine Recent Development
Table 73. Genetech Company Details
Table 74. Genetech Business Overview
Table 75. Genetech Prostate Cancer Molecular Diagnostics Product
Table 76. Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Genetech Recent Development
Table 78. Gpmedical Company Details
Table 79. Gpmedical Business Overview
Table 80. Gpmedical Prostate Cancer Molecular Diagnostics Product
Table 81. Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Gpmedical Recent Development
Table 83. Premed Company Details
Table 84. Premed Business Overview
Table 85. Premed Prostate Cancer Molecular Diagnostics Product
Table 86. Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Premed Recent Development
Table 88. Berryoncology Company Details
Table 89. Berryoncology Business Overview
Table 90. Berryoncology Prostate Cancer Molecular Diagnostics Product
Table 91. Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Berryoncology Recent Development
Table 93. Gene+ Company Details
Table 94. Gene+ Business Overview
Table 95. Gene+ Prostate Cancer Molecular Diagnostics Product
Table 96. Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Gene+ Recent Development
Table 98. Annoroad Company Details
Table 99. Annoroad Business Overview
Table 100. Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Annoroad Recent Development
Table 102. Topgen Company Details
Table 103. Topgen Business Overview
Table 104. Topgen Prostate Cancer Molecular Diagnostics Product
Table 105. Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Topgen Recent Development
Table 107. Geneis Company Details
Table 108. Geneis Business Overview
Table 109. Geneis Prostate Cancer Molecular Diagnostics Product
Table 110. Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Geneis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Prostate Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Prostate Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Prostate Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Prostate Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Prostate Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Prostate Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Prostate Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Prostate Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Prostate Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Prostate Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Prostate Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Prostate Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Prostate Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Prostate Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Prostate Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Prostate Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Qiagen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Foundationmedicine Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Genetech Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Gpmedical Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Premed Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Berryoncology Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Gene+ Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Annoroad Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Topgen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Geneis Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---